Compare Inovio Pharmaceuticals Inc (INO) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Toronto-Dominion Bank — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Toronto-Dominion Bank trades at $120.27 (market cap $197.03B). The key difference: Toronto-Dominion Bank is far larger — about 2207.1× Inovio Pharmaceuticals Inc's market cap, and Toronto-Dominion Bank pays a 2.62% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | TD | |
|---|---|---|
Market Cap | $89.27M | $197.03B |
Sector | Health | Financials |
52-Week High | $2.87 | $124.80 |
52-Week Low | $1.05 | $72.55 |
Enterprise Value | $60.28M | — |
Dividend Yield | — | 2.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
